Creative Biolabs Expands Complement Assay Services to Accelerate Therapeutics Development

Creative Biolabs, a leading biotechnology research service provider based in Shirley, NY, has announced the expansion of its complement assay service portfolio. This move is designed to assist pharmaceutical and biotechnology companies in accelerating the development of next-generation complement therapeutics. The enhanced capabilities aim to provide researchers with reliable analytical solutions for evaluating complement pathway activity, therapeutic mechanisms, and candidate performance during preclinical development. As interest in complement-targeted drug discovery grows, the need for specialized functional assays has become paramount. Researchers often face challenges such as complex biological pathways, assay optimization, target validation, and the need for reproducible data. Creative Biolabs addresses these hurdles by offering customizable complement assay solutions that span early discovery and preclinical evaluation.

Among the expanded offerings, the C3b deposition assay service stands out as a powerful tool for analyzing complement activation by measuring C3b deposition, a critical marker in the complement cascade. This assay supports the characterization of complement-targeting antibodies, proteins, and other therapeutic candidates by providing quantitative data related to pathway regulation and biological activity. Additionally, the company provides a hemolytic inhibition assay to evaluate the ability of test candidates to inhibit complement-mediated cell lysis, enabling comparisons of inhibitory activity under defined experimental conditions. Furthermore, the individual components activity test services allow for detailed analysis of specific complement proteins, facilitating mechanism studies and pathway investigations.

With extensive expertise in biotechnology research and assay development, Creative Biolabs delivers flexible and reliable testing solutions that help reduce research complexity and improve development efficiency. The company supports life science organizations worldwide with services in complement research, antibody development, protein engineering, and related fields. This expansion reflects Creative Biolabs' continued commitment to supporting complement-focused research by combining scientific expertise with customized assay solutions. Researchers and biotechnology organizations seeking reliable complement testing solutions can explore these advanced services at their website. Creative Biolabs serves pharmaceutical, biotechnology, and academic organizations globally, helping to advance complex biological discoveries and accelerate drug development programs.